UK Food System Under Scrutiny as Treasury Proposes Supermarket Price Caps Amid Climate and Global Pressures Home Equity Loan and HELOC Rates Stay Low as of May 27 2026 But Comparison Shopping Remains Key One House Three Owners How the American Dream of Homeownership Grows More Costly Amazon Expands AI Shopping Technology to Retailers Secures Kate Spade as Customer Standard Chartered CEO Apologizes After Referring to Workers as Lower Value Human Capital Canaccord Genuity Raises Biodesix Price Target on Upgraded Revenue Forecast POCI Q1 2026 Earnings Narrow Loss Amid Quiet Quarter Revenue Data Not Disclosed INGR Q1 2026 Earnings EPS Misses Estimates Amid Cost Pressures Stock Holds Steady LQR House Inc YHC Q3 2024 Earnings EPS Miss Widens as Losses Deepen Stock Declines 7 CZWI Q1 2026 Earnings EPS Beats Estimates Revenue Data Not Disclosed SMPL Q1 2026 Earnings EPS Surges Past Estimates with 118 Surprise NIO Q1 2026 Earnings EPS Beat Masks Continued Operational Challenges Guidewire Software GWRE Retreats from Resistance Key Levels to Watch Strawberry Fields REIT STRW Modestly Advances as It Approaches Key Resistance Level Shore Bancshares SHBI Edges Higher Approaching Key Resistance at 2149 Valley National Bancorp Preferred Stock VLYPO Holds Steady Near 2512 Key Support and Resistance in Focus Marvell Technology MRVL Declines 46 as Bearish Pressure Intensifies Key Support Levels in Focus Micron Shares Surge to Record High Following Analyst PriceTarget Upgrade Byju Raveendran Sentenced to Jail by Singapore Court for Contempt StateFederal Regulatory Clash Escalates Over Prediction Markets 16 States Pursue Legal Action Deutsche Bank Aktiengesellschaft DB Shows Resilient Core Business Despite Market Volatility RubioModi Talks Signal Potential Shifts in USIndia Trade and Energy Cooperation Petrobras Advances Offshore Projects with SBM Offshore Vessel Agreements Amazon UK Director Challenges Blame on Youth Unemployment Points to Education System Gap Processa Pharmaceuticals PCSA Q4 2025 Earnings EPS Misses Estimates by a Wide Margin as PreRevenue Biotech Advances Pipeline Enliven Therapeutics ELVN Pulls Back 263 as Resistance Holds Support Levels in Focus